Marinus Pharmaceuticals Inc (MRNS):企業の財務・戦略的SWOT分析

◆英語タイトル:Marinus Pharmaceuticals Inc (MRNS) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH141470FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥84,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥126,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Marinus Pharmaceuticals Inc (Marinus Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes medicines for the treatment of epilepsy and other neuropsychiatric disorders. The company is evaluating its lead product candidate Ganaxolone, a gamma-aminobutyric acid (GABA) modulator, against status epilepticus (SE), cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder, PCDH19-related epilepsy and tuberous sclerosis complex (TSC). It works in collaboration with The Tuberous Sclerosis Alliance, Postpartum Support International, Epilepsy Foundation of America and PCDH19 Alliance for advancing its therapeutics. Marinus is headquartered in Radnor, Pennsylvania, the US.

Marinus Pharmaceuticals Inc Key Recent Developments

Mar 24,2021: Marinus Pharmaceuticals Appoints Dr. Saraswathy (Sara) Nochur to Board of Directors
Feb 23,2021: Marinus Pharmaceuticals Unveils New Brand as the Company Prepares for Commercialization
Feb 23,2021: Marinus Pharmaceuticals unveils new brand as the company prepares for commercialization
Feb 17,2021: Marinus Pharmaceuticals to Participate in Multiple Investor Healthcare and Life Sciences Conferences
Dec 21,2020: Marinus Pharmaceuticals announces Iis addition to the Nasdaq Biotechnology Index

This comprehensive SWOT profile of Marinus Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Marinus Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Marinus Pharmaceuticals Inc – Key Information
Marinus Pharmaceuticals Inc – Overview
Marinus Pharmaceuticals Inc – Key Employees
Marinus Pharmaceuticals Inc – Key Employee Biographies
Marinus Pharmaceuticals Inc – Key Operational Heads
Marinus Pharmaceuticals Inc – Major Products and Services
Marinus Pharmaceuticals Inc – History
Marinus Pharmaceuticals Inc – Company Statement
Marinus Pharmaceuticals Inc – Locations And Subsidiaries
Marinus Pharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Marinus Pharmaceuticals Inc – Business Description
Marinus Pharmaceuticals Inc – Corporate Strategy
Marinus Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Marinus Pharmaceuticals Inc – Strengths
Marinus Pharmaceuticals Inc – Weaknesses
Marinus Pharmaceuticals Inc – Opportunities
Marinus Pharmaceuticals Inc – Threats
Marinus Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Marinus Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Marinus Pharmaceuticals Inc, Key Information
Marinus Pharmaceuticals Inc, Key Ratios
Marinus Pharmaceuticals Inc, Share Data
Marinus Pharmaceuticals Inc, Major Products and Services
Marinus Pharmaceuticals Inc, History
Marinus Pharmaceuticals Inc, Key Employees
Marinus Pharmaceuticals Inc, Key Employee Biographies
Marinus Pharmaceuticals Inc, Key Operational Heads
Marinus Pharmaceuticals Inc, Other Locations
Marinus Pharmaceuticals Inc, Subsidiaries
Marinus Pharmaceuticals Inc, Key Competitors
Marinus Pharmaceuticals Inc, SWOT Analysis
Marinus Pharmaceuticals Inc, Ratios based on current share price
Marinus Pharmaceuticals Inc, Annual Ratios
Marinus Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Marinus Pharmaceuticals Inc (MRNS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cineworld Group Plc:企業の戦略・SWOT・財務分析
    Cineworld Group Plc - Strategy, SWOT and Corporate Finance Report Summary Cineworld Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sonova Holding AG (SOON):企業の財務・戦略的SWOT分析
    Sonova Holding AG (SOON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Pulmonx Corp:医療機器:M&Aディール及び事業提携情報
    Summary Pulmonx Corp (Pulmonx) is a medical device company that manufactures and markets minimally invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorders. The company uses combination of assessment tools and therapeutics which enables physicians to successfu …
  • Belk Inc:戦略・SWOT・企業財務分析
    Belk Inc - Strategy, SWOT and Corporate Finance Report Summary Belk Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Gardiner & Theobald LLP:企業の戦略的SWOT分析
    Gardiner & Theobald LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Meridian Bancorp Inc (EBSB):企業の財務・戦略的SWOT分析
    Meridian Bancorp Inc (EBSB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • ProSciento Inc-医療機器分野:企業M&A・提携分析
    Summary ProSciento Inc (ProSciento), formerly Profil Institute for Clinical Research Inc is contract research organization that concentrates on developing drugs and devices for the treatment of obesity, diabetes and metabolic diseases. The organization offers services such as clinical development an …
  • Australian Postal Corporation:企業の戦略・SWOT・財務分析
    Australian Postal Corporation - Strategy, SWOT and Corporate Finance Report Summary Australian Postal Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Fossil Group, Inc. (FOSL):企業の財務・戦略的SWOT分析
    Fossil Group, Inc. (FOSL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Canadian Tire Corp Ltd (CTC.A):企業の財務・戦略的SWOT分析
    Canadian Tire Corp Ltd (CTC.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • HDR Inc:企業の戦略的SWOT分析
    HDR Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Krka dd Novo Mesto (KRKG):企業の財務・戦略的SWOT分析
    Summary Krka dd Novo Mesto (Krka) is a manufacturer and distributor of pharmaceutical products. The company provides prescription pharmaceuticals, non-prescription products, and animal health products. It offers prescription products for cardiovascular diseases, diseases of alimentary tract and meta …
  • Lanxess AG:企業の戦略・SWOT・財務情報
    Lanxess AG - Strategy, SWOT and Corporate Finance Report Summary Lanxess AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Creganna Medical:企業の戦略的SWOT分析
    Creganna Medical - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Koch Membrane Systems Inc:企業の戦略的SWOT分析
    Koch Membrane Systems Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Beach Energy Limited:企業の戦略・SWOT・財務分析
    Beach Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Beach Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Gemini Corp (GKX)-石油・ガス分野:企業M&A・提携分析
    Summary Gemini Corporation (Gemini) is an oil and gas engineering company that provides engineering, field and environmental solutions. The company offers services including project management systems, fabrication, maintenance, procurement, construction, land, environmental, regulatory, and reclamat …
  • QIAGEN N.V.:企業の戦略・SWOT・財務情報
    QIAGEN N.V. - Strategy, SWOT and Corporate Finance Report Summary QIAGEN N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • West Pharmaceutical Services Inc (WST)-医療機器分野:企業M&A・提携分析
    Summary West Pharmaceutical Services Inc (West Pharmaceutical) manufactures components and systems for packaging and delivery of injectable drugs and delivery system components for use healthcare, pharmaceuticals and consumer product industries. Its product and services include stoppers and seals fo …
  • API Technologies Corp.:戦略・SWOT・企業財務分析
    API Technologies Corp. - Strategy, SWOT and Corporate Finance Report Summary API Technologies Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆